NARGIZA ALIEV: Open Payments
NPI 1205358348 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 84 payments from 24 companies in 2025. Trend: 2023 $1,629 · 2024 $1,274 · 2025 $1,363
Food & beverage: $1,363
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $246 |
| Abbott Laboratories | 18 | $170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $89 |
| IBSA Pharma Inc. | 5 | $83 |
| Mannkind Corporation | 5 | $80 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| Insulet Corporation | 3 | $56 |
| Dexcom, Inc. | 3 | $55 |
| BETA BIONICS, INC. | 3 | $55 |
| Soleno Therapeutics, Inc. | 2 | $47 |
Products named: FREESTYLE LIBRE 3, Ozempic, Wegovy, JARDIANCE, Tirosint, AFREZZA, GVOKE HYPOPEN, Omnipod.
Industry payments across TX — which companies pay providers there.
